Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.

4.4.2013 -Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.

Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc.

3.6.2013 - Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc.

Acquisition Expected to Give Ajinomoto Co., Inc. Entry Into the Contract Development and Manufacturing Market

Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production

2.26.2013 - Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production

Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen

10.24.2012 - Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen

Althea Technologies Announces Expanded Roles for Key Executives

9.24.2012 - Althea Technologies Announces Expanded Roles for Key Executives

Three Key Leaders Promoted as Company Matches Leadership Talent to Expanding Business Priorities

Althea Technologies Appoints Dr. Dennis Fenton as Chairman of its Scientific Advisory Board

6.19.2012 - Althea Technologies Appoints Dr. Dennis Fenton as Chairman of its Scientific Advisory Board

Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing and Jack Wright, VP, Sales and Marketing

5.2.2012 - Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing and Jack Wright, VP, Sales and Marketing

Allena Pharmaceuticals Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies

3.28.2012 - Allena Pharmaceuticals Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies

Althea Technologies Featured on NBC San Diego

11.1.2011 - Althea Technologies Featured on NBC San Diego

Althea Technologies Appoints Martha J. Demski as Senior Vice President & Chief Financial Officer

9.8.2011 - Althea Technologies Appoints Martha J. Demski as Senior Vice President & Chief Financial Officer

Althea Technologies Hosts Health and Wellness Week

8.11.2011 - Althea Technologies Hosts Health and Wellness Week

Althea Technologies Receives FDA Approval To Initiate Commercial Manufacturing

6.28.2011 - Althea Technologies Receives FDA Approval To Initiate Commercial Manufacturing

Althea and Biotest Establish Commercial Filling Agreement

5.3.2011 - Althea and Biotest Establish Commercial Filling Agreement

Althea Technologies Expands Service Offering To Packaging and Labeling Through A Co-Marketing Agreement With Sherpa Clinical Packaging

3.24.2011 - Althea Technologies Expands Service Offering To Packaging and Labeling Through A Co-Marketing Agreement With Sherpa Clinical Packaging

Althea Technologies Appoints Dr. Catherine J. Mackey to the Board of Directors

12.13.2010 - Althea Technologies Appoints Dr. Catherine J. Mackey to the Board of Directors

Althea Technologies Announces Appointment Of Rick Hancock As President

11.11.2010 - Althea Technologies Announces Appointment Of Rick Hancock As President.

Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line

10.19.2010 - Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line.

Althea Technologies Acquires Altus Pharmaceuticals’® Assets and IP Portfolio

5.2.2010 - Althea Technologies Acquires Altus Pharmaceuticals’® Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.

Althea Technologies Adds Formulation Development to its Integrated Offering of Contract Services

11.5.2009 Althea Technologies Adds Formulation Development to its Integrated Offering of Contract Services, appoints Dr. James Matsuura as Director, Formulation Development

Althea Technologies Completes New State-of-the-Art, Commercial-Scale, Biologics and Injectables Manufacturing Facility

4.30.2009 Althea Technologies Completes New State-of-the-Art, Commercial-Scale, Biologics and Injectables Manufacturing Facility

News

Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.

Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc.

Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production

Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen

Althea Technologies Announces Expanded Roles for Key Executives

Althea Technologies Appoints Dr. Dennis Fenton as Chairman of its Scientific Advisory Board

Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing and Jack Wright, VP, Sales and Marketing

Allena Pharmaceuticals Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies

Althea Technologies Featured on NBC San Diego

Althea Technologies Appoints Martha J. Demski as Senior Vice President & Chief Financial Officer

Althea Technologies Hosts Health and Wellness Week

Althea Technologies Receives FDA Approval To Initiate Commercial Manufacturing

Althea and Biotest Establish Commercial Filling Agreement

Althea Technologies Expands Service Offering To Packaging and Labeling Through A Co-Marketing Agreement With Sherpa Clinical Packaging

Althea Technologies Appoints Dr. Catherine J. Mackey to the Board of Directors

Althea Technologies Announces Appointment Of Rick Hancock As President

Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line

Althea Technologies Acquires Altus Pharmaceuticals’® Assets and IP Portfolio

Althea Technologies Adds Formulation Development to its Integrated Offering of Contract Services

Althea Technologies Completes New State-of-the-Art, Commercial-Scale, Biologics and Injectables Manufacturing Facility

More Articles...